Product Information
LEVO-T 300 MCG TABLET is a generic product labeled by Neolpharma, Inc., priced at $0.1084 per EA under NDC 55466011511. Its NADAC has been published 517 times since Aug 3, 2016.
Strength
300 ug/1
Manufacturer
Neolpharma, Inc.NDC
55466011511
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021342On Market Since
10/29/2015
Pharmacological Classes
Price Statistics
The NADAC for LEVO-T 300 MCG TABLET has been published 517 times since Aug 3, 2016, and over the history we have for it it has declined 86.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1084 per EA |
|---|---|
| All-time high | $0.8465 (Oct 12, 2016) |
| All-time low | $0.0715 (Jul 17, 2024) |
| 52-week high | $0.1278 |
| 52-week low | $0.1084 |
| Median price | $0.4670 |
| Average price | $0.4265 |
| Largest weekly change | +78.9% (Aug 21, 2024) |
| Weeks tracked | 517 |
| Tracking since | Aug 3, 2016 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVO-T 300 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVO-T 300 MCG TABLET, manufactured by Neolpharma, Inc., is $0.1084 per EA (NDC 55466011511), effective Jun 24, 2026.
How has the price of LEVO-T 300 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVO-T 300 MCG TABLET has declined 86.0%. It has been tracked across 517 weekly CMS publications since Aug 3, 2016.
What are the highest and lowest recorded NADAC prices for LEVO-T 300 MCG TABLET?
Since Aug 3, 2016, the NADAC for LEVO-T 300 MCG TABLET has ranged from a low of $0.0715 (Jul 17, 2024) to a high of $0.8465 (Oct 12, 2016), with a median of $0.4670 per EA.
Are there cheaper alternatives to LEVO-T 300 MCG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LEVO-T 300 MCG TABLET, but none are currently priced below it.
Who manufactures LEVO-T 300 MCG TABLET?
LEVO-T 300 MCG TABLET (NDC 55466011511) is labeled by Neolpharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification